Abstract. The caudal-type homeobox gene Cdx2 encodes a transcription factor which in adult mammals is expressed in the cells of the intestinal epithelium and is thought to play an important role in their proliferation and differentiation. Cdx2 mediates apoptosis and suppresses tumorigenesis in many tissue types, but there are few data available on Cdx2 expression and its relationship to tumor kinetics in gastric cancer. To gain better insight into the involvement of Cdx2 in the biological characteristics of gastric cancer, we investigated the effect of Cdx2 overexpression on the progression of gastric carcinoma cells. A gastric cancer cell line stably overexpressing Cdx2 (MGC-803/Cdx2) was established. The influence of Cdx2 overexpression on in vitro cell growth was assessed by measuring cell survival, colony formation and cell cycle progression. The results clearly showed that overexpression of Cdx2 significantly inhibited cell growth and proliferation, blocking entry into the S phase of the cell cycle. MGC-803/Cdx2 cells also had a higher apoptotic rate than control cells. In addition, Cdx2 reduced the motility and invasion of gastric cancer cells. In summary, Cdx2 overexpression can effectively inhibit gastric cancer progression and may be used as a potent therapy.
Introduction
Homeobox genes encode transcription factors that play crucial roles in early developmental processes including patterning and cell identity. Some are expressed in adulthood and alterations are linked to malformations, metabolic diseases, and cancers (1) . Cdx2 gene, a member of the caudal-related homeobox gene family, homologous to the Drosophila gene caudal, has an essential role during early development. The Cdx2 gene is an intestinal transcription factor that may be involved in the regulation of the proliferation and differentiation of intestinal epithelial cells (2, 3) . Cdx2 protein is predominantly expressed in the intestine and colon, but not in the normal epithelium of the esophagus and stomach through adulthood in humans and mice.
Initially, homeobox genes was suggested to behave as proto-oncogenes because substantial evidence indicates that their alterations participate in tumor genesis (4) . For example, overexpressing Cdx1 in the intestinal cell line has been reported to increase proliferation and differentiation but also transformational and tumorigenic activity. Meanwhile, Cdx2 induces intestinal metaplasia of stomach, esophagus and other issues and Cdx2-induced intestinal metaplasia itself causes carcinoma (5, 6) . However, as a nuclear transcription factor, Cdx2 has also been proved to be a tumor suppressor. A number of studies performed on several cancer cell lines have provided evidence that Cdx2 inhibits cell growth, stimulates overall cell differentiation and also promotes cell apoptosis (7, 8) . These results indicate that Cdx2 opposes the malignant behaviour of cancer cells. Apart from the effects reported on cell lines, a link has been proposed between colon cancers and Cdx2 status as human colorectal cancers and chemically induced colon tumors in the rat show reduced Cdx2 levels in relation to tumor grade (9, 10) .
Gastric carcinoma remains the second most common cause of cancer deaths on a worldwide basis. In China, there are 400,000 new cases of gastric cancer and 300,000 deaths annually, making gastric cancer the third most common type of cancer in China (11) . Dysregulation of gene expression is integral to the neoplastic process, and there is now compelling evidence implicating upregulation or downregulation of multiple genes in the development and progression of gastric cancer. However, the clinical significance and implication of Cdx2 expression in human gastric carcinoma are unclear.
We conducted this study to investigate the involvement of Cdx2 activity in the development and progression of gastric cancer. In this study, we constructed an eukaryotic expression vector with Cdx2 gene to determine the effects of Cdx2 overexpression on biological characteristics of gastric cancer in an in vitro cell model for gastric cancer. The longterm goals of our project are to exploit the potential use of Cdx2 as a marker for clinical diagnosis and prognosis of 
Materials and methods
Cell culture. The poorly differentiated human gastric adenocarcinoma cell line, MGC-803, was purchased from Cell Bank, Chinese Academy of Science, Shanghai, China, and cultured in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen, Gaithersburg, MD, USA). All media were supplemented with 10% heat-inactivated fetal bovine serum (Invitrogen), penicillin (100 U/ml), and streptomycin (100 μg/ml). The cells were cultured in an incubator at 5% CO 2 in air at 37˚C, with medium changes every 3 days.
Construction and transfection of the Cdx2 plasmid expression vector.
Plasmid pCMV-HA, purchased from Shanghai Cancer Institute, China, was used to construct the Cdx2 expression vector. The methods of pCMV-Cdx2-HA and transfection of MGC-803 gastric cancer cells with pCMV-HA or pCMV-Cdx2-HA have been previously described (12) . Briefly, a Cdx2 cDNA PCR product and pCMV-HA were digested with EcoRI. The digested PCR product was electrophoresed through and isolated from an agarose gel. After purification, it was ligated into the cut vector to form pCMV-Cdx2-HA. After the ligation, the plasmid was transformed into Escherichia coli TOP10 cells, and then planted on solid LB medium. Ampicillin-resistant colonies were cultured at 37˚C overnight in a rocking bed. The recombinant plasmid was prepared, and the sequences were verified by electrophoresis of the digested product. MGC-803 cells (1x10 5 ) were inoculated into a 6-well plate and transfected with pCMV-Cdx2-HA or pCMV-HA recombination plasmids when the confluence was 90%. Forty-eight hours after transfection, MGC-803 cells were diluted to 1:10 for passage, and cultured for at least 2 weeks in medium with G418.
RT-PCR analysis. Total cellular RNA was extracted from cells using TRIzol Reagent (Invitrogen) according to the manufacturer's instructions. RNA concentration was determined by measuring UV absorption. RNA was reverse transcribed to single-strand cDNA using a Revertaid First Strand cDNA Synthesis Kit (Fermentas International Inc., Canada). Table I shows the PCR primer sequences used in this study. The reaction contained 2 μg RNA, 1 μl random primer and DEPC-treated water added to the sample to a volume of 12 μl, incubated at 70˚C for 10 min and put on ice. Afterwards 4 μl of reaction buffer, 2 μl of dNTPs and 1 μl of RNase inhibitor were added. Samples were incubated at 25˚C for 5 min, and added 1 μl of M-MuLV reverse transcriptase was introduced. After incubation at 25˚C for 10 min, the samples were finally heated at 48˚C for 60 min. The reactions stopped by heating at 70˚C for 10 min, and the samples chilled on ice. The amplification for Cdx2 was done under the following conditions: 25 μl reaction mixture contained 2.5 μl of PCR buffer, 2 μl of dNTP, 2.5 units of Takara LA Taq polymerase (Takara, Japan), 1 μl of each primer, and 100 ng of cDNA at 94˚C for 5 min; then 94˚C for 45 sec, 56˚C for 30 sec, 72˚C for 1 min for 35 cycles, and finally at 72˚C for 10 min for balance. After PCR reaction, 2 μl of the amplified product was electrophoresed in 2% agarose gelatin gels buffered withc.
Western blot analysis. Cell lysates were prepared in a buffer containing 100 mM NaCl, 10 mM Tris-Cl (pH 7.6), 1 mM EDTA (pH 8.0), 1 μg/ml aprotinin, 100 μg/ml PMSF, and 1% (v/v) NP40. After protein quantification using the Lowry assay, equal amounts of protein were separated by SDS-PAGE and blotted onto nitrocellulose membranes by the semidry blotting method using a 3-buffer system. The membrane was blocked with 5% BSA in PBST (PBS, pH 7.5, containing 0.1% Tween-20) and incubated with a 1:1500 dilution of primary antibody (anti-Cdx2) (Pierce Biotechnology Inc., Rockford, IL, USA) overnight at 4˚C. The membrane was washed with PBST and incubated with a peroxidase-conjugated secondary antibody (1:2500) (Santa Cruz Biotechnology, Inc., CA, USA) for 1 h. Specific antibody binding was detected using a chemiluminescence detection system (Pierce) according to the manufacturer's recommendations. After the film had been developed, the membrane was stripped and reprobed with antibody against ß-actin (1:1000) (Santa Cruz Biotechnology Inc.) to confirm equal sample loading.
Cell proliferation and survival assay. The viability and proliferation of cells were determined by an MTS assay using a CellTiter 96 AQueous assay system (Promega, Madison, WI, USA), according to the manufacturer's instructions. Briefly, the cells were plated at 1x10 4 cells/well in 96-well plates and cultured for 7 days. MTS mixed with medium without serum was added to the cell cultures after removal of the old medium. The plates were incubated at 37˚C for 2 h, and the absorbance (A) at 490 nm was determined using a 96-well Opsys MR™ microplate reader (ThermoLabsystems, Chantilly, VA, USA) and Revelation™ QuickLink Software. The blank control wells with medium only were set as zero absorbance controls. The percentage of cell survival was calculated using the background-corrected absorbance: % Table I . The base sequence of primers for RT-PCR.
proliferation rate = 100xA of experimental well/A of untreated control well. All experiments were performed at least three times.
Colony formation assay. Cell suspensions from each group were diluted in DMEM supplemented with 10% FBS, and immediately replated in 6-well plates at 20 cells/cm 2 . The plates were incubated until the cells in the control wells had formed sufficiently large colonies. The colonies were fixed with 6% glutaraldehyde and stained with 0.5% crystal violet. The plates were photographed and their digital images were manually analyzed to determine the colony number.
Cell cycle analysis by flow cytometry. For cell cycle analysis, MGC-803 cells (1x10 6 ) were washed twice with ice-cold PBS, treated with trypsin, and fixed in cold 70% ethanol at 4˚C for 30 min. The cell pellet was incubated in a solution containing 50 ng/ml propidium iodide, 0.2 mg/ml RNase, and 0.1% Triton X-100 at room temperature for 30 min. Wound healing assay. The cells were cultured to confluence on 6-well plates. A central linear wound was made with a 200 μl sterile pipet tip. Media were changed gently to remove any floating cells. Phase micrographs of the wound cultures were taken at 0, 24, 48 and 72 h. The photographs were analyzed by measuring the distance from the wound edge of the cell sheet to the original wound site. Migration activity was calculated as the mean distance between edges of 3 points in 12 fields/well. Healing rate = (mean original distancemean distance at a time point)/mean original distance x100%. Each test group was assayed in triplicate.
Cell invasion assay. Cell invasion was assayed using Transwell chambers (6.5 mm; Corning, New York, USA) with 50 μl serum-free DMEM containing 1 μg/μl Matrigel (Dept. of Biology, Beijing University, China) in the upper chamber. The lower chamber was filled with 50 μl DMEM containing 0.1 μg/μl fibronectin (Beijing University). Cells (1x10 5 ) were resuspended in 100 μl DMEM with 1% fetal calf serum and plated into the upper chamber. The lower chamber was filled with 600 μl DMEM containing 0.1% ABS. After incubation at 5% CO 2 in air at 37˚C for 24 h, the number of cells on the undersurface of the polycarbonate membranes that were stained with Giemsa was visually scored in 5 random fields at x400 magnification in a light microscope.
Statistical analysis. Data are expressed as mean ± standard error of the mean (SEM) analyzed by SPSS 13.0 (SPSS Inc., Chicago, IL, USA) and Origin 7.5 software programs (OriginLab Co., Northampton, MA, USA). Student's t-test was used to measure statistical significance between two treatment groups. Multiple comparisons were performed with a one-way analysis of variance (ANOVA). Data were considered significant at P<0.05.
Results
Construction and transfection with the pCMV-Cdx2-HA recombinant vector. To examine the effect of Cdx2 on gastric tumor cell progression in vitro, the plasmid pCMV-HA was used to construct the Cdx2 expression vector, pCMV-Cdx2-HA. The MGC-803 cell line was engineered to stably express increased levels of Cdx2 protein, and the engineered cell line is referred to as MGC-803/Cdx2. A control cell line was transfected with the empty vector and referred to as MGC-803/EV. mRNA and protein levels of Cdx2 in MGC-803 cells were validated by reverse transcription-polymerase chain reaction (RT-PCR) with primers specific to Cdx2 and Western blotting with antibody against Cdx2, respectively. An obvious 961 bp band was observed following gel electrophoresis of RT-PCR products amplified from MGC-803/Cdx2 cellular RNA, whereas no 961 bp band was observed following RT-PCR of MGC-803 or MGC-803/EV cellular RNA (Fig. 1) . In addition, markedly higher levels of Cdx2 protein were expressed in MGC-803/Cdx2 cells. In contrast, no Cdx2 expression was observed in MGC-803 or MGC-803/EV cells (Fig. 2) . The data suggest that the pCMV-Cdx2-HA recombinant vector was successfully constructed and Cdx2 was stably overexpressed in MGC-803/Cdx2 cells in vitro. the MTS assay (Fig. 3) . MGC-803/EV and MGC-803 cells had about 1.6-fold higher mean proliferation rates than MGC-803/Cdx2 cells (P<0.05). We also observed that MGC-803/ Cdx2 cells grew slower than MGC-803 and MGC-803/EV cells, consistent with the elevated levels of Cdx2 in MGC-803/ Cdx2 cells and indicative of a suppressive effect of Cdx2 on MGC-803 cell growth and survival.
Cdx2 overexpression inhibits cell growth and proliferation in gastric cancer MGC-803 cells. We then determined the in vitro
To confirm the inhibitory effect of Cdx2 on the growth of MGC-803 cells, colony formation was assayed to check the capability of the cell lines to grow in an anchorage-independent environment (soft agarose). The three cell lines were able to form colonies in soft agarose, but the number and size of the colonies were not consistent across the cell lines (Fig. 4A) . The number of colonies formed by MGC-803/Cdx2 cells after 3 weeks of culture was 26.1±1.3, which represents a 59.7 and 62.1% decrease, respectively, when compared with the MGC-803/EV and MGC-803 cells (P<0.05) (Fig. 4B) . Together, the data suggest that Cdx2 inhibits cell growth and proliferation in the gastric cancer cell system.
Effect of Cdx2 overexpression on cell cycle control in gastric cancer MGC-803 cells.
Flow cytometry was used to determine whether the inhibitory effect of Cdx2 on MGC-803 cell proliferation was mediated, at least in part, by cell cycle progression. The following cell cycle profile for MGC-803/ Cdx2 cells was seen: 47.1% were in G0/G1 phase and 35.8% were in S phase, with a 32.3 and 38.9% increase in G0/G1 phase cell population and a 26.5 and 31.5% decrease in S phase cell population compared to MGC-803/EV and MGC-803 cells, respectively (P<0.05) (Table II and Fig. 5 ). The data indicate that cell growth inhibition by Cdx2 is associated with significant cell cycle arrest at the G0/G1 phase and 
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suggest that Cdx2 suppresses cell proliferation by controlling the G1 and S checkpoints and inducing a specific block in cell cycle progression.
Cdx2 overexpression induces cellular apoptosis.
To confirm that Cdx2 induces MGC-803 cell apoptosis, cells were stained with Annexin V-FITC and PI before analysis by flow cytometry. As indicated in Fig. 6 , the percentage of MGC-803/ Cdx2 cells that were Annexin V + /PI -, apoptotic fraction, was significantly higher than that of MGC-803/EV or MGC-803 cells (P<0.05). This finding implies that overexpression of Cdx2 could induce apoptosis in gastric cancer MGC-803 cells.
Cdx2 overexpression inhibits migration and invasion of gastric cancer cells.
We measured the ability of three cell groups to migrate and invade using the wound healing assay and invasion assay system. A monolayer of cells was scratched, and the distance between the wound edges was determined at 0, 24, 48 and 72 h. MGC-803/Cdx2 cells showed lower migration ability at all time-points compared to both the controls (P<0.05). The relative migration of MGC-803/Cdx2 cells after 48 h was 59.6±5.3%, which was 23.7 and 28.2% less than that of MGC-803/EV and MGC-803 cells, respectively (Fig. 7) .
After the cells were incubated for 24 h in the invasion assay system, the numbers of MGC-803/EV and MGC-803 cells that had moved through the membrane of the Matrigel chamber were about 2.7-fold higher than that of MGC-803/Cdx2 cells (P<0.05) (Fig. 8) . The results indicate that Cdx2 reduces the migration and invasion ability of gastric cancer MGC-803 cells. 
Discussion
Homeobox genes encode nuclear transcription factors involved in patterning and cell differentiation during development (13). They have also been identified as a new class of protooncogenes (4), and substantial evidence indicates that homeobox gene alterations participate in tumorigenesis (14) . Considerable progress in understanding the function of homeobox genes arose from the finding that they regulate molecules involved in cellular interactions such as cell Table II . Cell cycle analysis by flow cytometry in gastric cancer MGC-803 cells. ---------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------- adhesion molecules and extracellular matrix components (15) . Homeobox genes themselves are regulated by other homeobox genes (16) , retinoids (17) and/or growth factors (18) . The caudal-related homeobox gene Cdx2 encodes a homeodomain transcription factor required for development and maintenance of the intestinal epithelium (19, 20) . Cdx2 expression in adults is restricted to intestinal epithelial cells, where it maintains the differentiated phenotype of mature enterocytes by regulating expression of intestine-specific genes, including guanylyl cyclase C (GCC), lactase, sucraseisomaltase and LI-cadherin (21) (22) (23) . Also, Cdx2 regulates the expression of ubiquitous genes important in controlling cell dynamics, including adhesion, proliferation, cell cycle regulation and apoptosis (24) (25) (26) . The homeotic function of Cdx2 is underscored by loss of the cognate enterocyte phenotype in intestinal neoplasms arising in the proximal colon of Cdx2 +/-mice upon biallelic inactivation of Cdx2 (9, 27) . Conversely, ectopic expression of Cdx2 in squamous epithelial cells of the forestomach induces intestinal metaplasia in transgenic mice (28, 29) .
Beyond its homeotic role, Cdx2 may be an important tumor suppressor in carcinogenesis (2, 30) . Thus, expression of Cdx2 mRNA and protein is reduced or lost in some human tumors (31) (32) (33) (34) . However, in some analyses, immunohistochemistry revealed Cdx2 protein expression in most human colonic adenocarcinomas examined (3, 35) . In animal models, biallelic inactivation of Cdx2 results in the formation of hamartomatous tumors characterized by gastric heteroplasia in the proximal colon (36) . Similarly, whereas adenomatous polyposis coli heterozygous (APC +/-) mice develop adenomatous polyposis of the small intestine, APC +/-Cdx2 +/-mice develop polyposis of the colon (37) . Moreover, the procarcinogen azoxymethane induced invasive adenocarcinoma of the distal colon in Cdx2 +/-mice but not wild-type littermates (9) . Further, overexpression of Cdx2 in human colon cancer cells induces a less malignant phenotype, inhibiting proliferation, invasion, and migration while promoting the expression of genes characteristic of mature enterocytes (20, 26, 32, 38, 39) .
Thus, the prevalent paradigm suggests that Cdx2 is a tumor suppressor whose reduced expression and/or function contributes to initiation and progression of cancer (2, 30, 37) . This hypothesis presumes that promotion of carcinogenesis reflects loss of Cdx2 expression and/or function in tumor cells relative to normal intestinal epithelium. In the present study, we constructed recombinant pCMV-Cdx2-HA plasmids and successfully transfected these plasmids into human gastric carcinoma MGC-803 cells. Our results clearly showed that Cdx2 overexpression in MGC-803 cells inhibited cell growth and blocked transition from G1 to S phase. We also showed that overexpression of Cdx2 induced apoptosis. Furthermore, Cdx2 overexpression in MGC-803 cells reduced cellular migration, invasion and colony formation, providing evidence that overexpression of Cdx2 suppressed tumor progression. This study provides experimental evidence that Cdx2 is a tumour suppressor gene involved in cancer progression in gastric cancer. This action is functionally and geographically distinct from its homeotic role during gut development.
Unlike tumor suppressor genes such as APC and p53, which act in the colon and also outside of the gut (40, 41) , Cdx2 is the intestine specific tumor suppressor. However, little is known about the mechanisms regulating Cdx2 gene transcription and the mechanisms causing its decreased expression in the progression to carcinomas. Both transcriptional and post-transcriptional mechanisms controlling Cdx2 levels are likely to play key roles in the determination of intestinal cell fate, differentiation and transformation. Cdx2 is likely to contain multiple phosphorylation sites that either positively or negatively modulate its activity in response to different signaling pathways. Two studies had already reported the occurrence of p38· and ERK-dependent phosphorylation of Cdx2 within the amino-terminal region, upstream of the DNA-binding homeodomain (42, 43) . Except that, Gross et al revealed a novel and important mechanism of regulation for the Cdx2 transcription factor (44) . This occurs via phosphorylation of the Cdx2 protein at serine 281 by cyclin-dependent kinase 2 (Cdk2), a checkpoint cell cycle regulator, controlled by cyclins A and E at the G1/S and S/G2 transitions.
One characteristic feature of any malignant tumor is the ability of tumor cells to invade and migrate into surrounding and/or distal tissue. Adhesion molecules such as cadherins are considered important during the process of invasion or metastasis. Loss of E-cadherin expression in tumor cells is known to be associated with invasion and metastasis, as well as transition from adenoma to carcinoma. Recently, it was found that serum-soluble E-cadherin is a useful prognostic marker for gastric cancer. The relationship between Cdx2 and adhesion molecules was previously studied in human colon cancer cell lines (45) (46) (47) . The Cdx2-overexpressing cell line displays high resistance to trypsin treatment at confluency, perhaps as a result of increased expression of E-cadherin in these cells. In the present study, we found inhibition of migration and invasion potential of MGC-803 cells in vitro because of the transfection of pCMV-Cdx2-HA plasmids.
In summary, the Cdx2 homeobox gene has multiple roles in the gut. During development it has a homeotic function and is an essential component of the gene complex required for midgut morphogenesis. The present data suggest that it exerts a homeostatic function in adults, whose overexpression inhibits tumor progression in human gastric carcinoma MGC-803 cells. Hence the tumor suppressor Cdx2 may be a putative target for anti-gastric cancer therapy, with the aim of restoring its expression to slow down or prevent malignant progression.
